K

Kriya Therapeutics

144 employees

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Gene Therapy
Life Science

Date founded

2019

Funding rounds raised

Total raised

$270M

from 25 investors over 25 rounds

K

Kriya Therapeutics raised $150M on July 26, 2023

Investors: Patient Square Capital

K

Kriya Therapeutics raised $270M on May 16, 2022

Investors: Narya, Transhuman Capital, Dexcel Pharma, QVT Financial LLP, Patient Square Capital, Foresite Capital and JDRF T1D Fund

K

Kriya Therapeutics raised $100M on July 14, 2021

Investors: Narya, Transhuman Capital, QVT Financial LLP, Dexcel Pharma, Foresite Capital, Woodline Partners LP, Patient Square Capital and JDRF T1D Fund

K

Kriya Therapeutics raised $81M on May 12, 2020

Investors: Transhuman Capital, Narya, Sahsen Ventures, LLC, Foresite Capital, Dexcel Pharma, Amplo, JDRF T1D Fund and QVT Financial LLP

K

Kriya Therapeutics raised undisclosed on October 1, 2019

Investors: Transhuman Capital

FAQ